A carregar...

Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis

PURPOSE: To characterize the post-marketing reporting of serotonin syndrome (SS) due to drug-drug interactions (DDIs) with linezolid and investigate the relationship with pharmacokinetic/pharmacodynamic (PK/PD) properties of serotonergic agents. METHODS: We queried the worldwide FDA Adverse Event Re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Clin Pharmacol
Main Authors: Gatti, Milo, Raschi, Emanuel, De Ponti, Fabrizio
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7803711/
https://ncbi.nlm.nih.gov/pubmed/32901348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-020-02990-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!